Breast Cancer Trial, Recruiting NCT07541664 Sponsor: Fudan University Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07541664
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing to take part and sign a written consent form
  • Women aged 18 or older
  • People who have been diagnosed with invasive breast cancer, confirmed through a tissue sample test
  • People who are planning to receive treatment before surgery (called neoadjuvant therapy)
  • People who completed a mental and emotional wellbeing assessment before starting pre-surgery treatment, and scored at mild severity or higher in at least two of these areas: anxiety, depression, insomnia, or psychological distress
  • People who are willing to attend follow-up appointments and take part as required throughout the study
  • People with normal hearing, or no severe hearing difficulties
  • People who own a smartphone and are able to use mobile apps independently

Who may not be able to join:

  • People whose cancer has spread to distant parts of the body
  • People with a history of other cancers, except for certain skin cancers that have been fully treated, early-stage cervical cancer, or other cancers where the person has been cancer-free for more than 5 years (confirm with trial site)
  • People with a weakened immune system or HIV infection
  • People with serious problems affecting the heart, lungs, liver, or kidneys
  • People with an infection that is not under control, or an active infection
  • People who are pregnant or currently breastfeeding
  • People whose psychological or cognitive condition would make it impossible to complete the mental and emotional wellbeing assessments
  • People who have previously been diagnosed with bipolar disorder, schizophrenia, schizoaffective disorder, or a psychiatric condition caused by another medical illness

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
25 March 2026
Est. completion
31 January 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Insomnia severity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov